SCHEMBL5134147

SCHEMBL5134147

CCn1nc(C(C)(C)C)c2nc(N(Cc3cccc(N4CCOCC4)c3)CC(C)C)ncc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.34
AGXT P21549 1/20 0.34
ALKBH1 Q13686 1/20 0.32
METAP2 P50579 1/20 0.32
LCK P06239 1/20 0.31
KDR P35968 1/20 0.31
DHFR P00374 1/20 0.31
CETP P11597 2/20 0.31
KDM5B Q9UGL1 1/20 0.31
AOC3 Q16853 2/20 0.31
CFTR P13569 1/20 0.31
NPSR1 Q6W5P4 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SYK P43405 1/20 0.30
SLC16A3 O15427 1/20 0.30
SLC16A1 P53985 1/20 0.30
MCTS1 Q9ULC4 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5134689 0.80 RORC (0.35) RORCAGXTALKBH1LCKKDR
SCHEMBL4901550 0.79 RORC (0.35) RORCAGXTMETAP2KDM5BCFTR
SCHEMBL4893446 0.68 KDM4E (0.37) RORCAGXTKDM5BCFTRNPSR1
SCHEMBL4895781 0.67 KDM4E (0.38) RORCAGXTKDM5BCFTRNPSR1
SCHEMBL5141914 0.67 AGXT (0.39) RORCAGXTDHFRAOC3SLC16A3
SCHEMBL4903611 0.67 KDM4E (0.36) AGXTKDM5BCFTRNPSR1SMN1; SMN2
SCHEMBL4282621 0.65 AGXT (0.36) AGXTAOC3SLC16A3SLC16A1MCTS1
SCHEMBL4901484 0.64 PDE5A (0.42) ALDH1A1
SCHEMBL4903686 0.63 KDM4E (0.37) AGXTKDM5BAOC3CFTRNPSR1
SCHEMBL22242840 0.63 AGXT (0.57) RORCAGXTAOC3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008071650-A2 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-19 WO claimed
WO-2008071650-A2 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS N.V. (BE) 2008-06-19 WO disclosed